COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 52: Articles 511-520  | Next

Risk of interstitial lung disease in COVID-19 patients with autoimmune diseases treated with antiviral agents: a retrospective cohort study
Cheng, I.-H., Huang, X., Wang, Y.-H., Hung, Y.-m., Wei, J. C.-C.
10.64898/2026.01.30.26345205 — Posted: 2026-02-01
Evaluating the Usability of Co-Created Public-Facing Knowledge Mobilization Resources for the Canadian Guidelines for Post COVID-19 Condition
Elliott, S. A., Cyrkot, S., Scott, S. D., Travis, H., Motilall, A., Wiercioch, W., Pardo, J. P., Schunemann, H. J., Nieuwlaat, R., Hartling, L.
10.64898/2026.01.29.26344622 — Posted: 2026-01-30
Adverse Events After LP.8.1-Containing COVID-19 mRNA Vaccines
Hviid, A., Thiesson, E. M., Andersson, N. W.
10.64898/2026.01.25.26344612 — Posted: 2026-01-30
Displayed and Encoded Antigens on Adenovirus Vectors Optimize Humoral and Cellular Immune Responses in Rhesus Macaques
Li, Z., Dicks, M. D. J., Rose, L. M., Russell, R. A., McMahan, K., Lasrado, N., Nkolola, J., Borducchi, E., Liu, J., Biswas, S., Barouch, D. H.
10.64898/2026.01.29.702655 — Posted: 2026-01-30
Association Between SARS-CoV-2 Mutations and Disease Severity Reveals Risk and Protective Effects Among Community-Sampled Patients in Israel
Eliyahu, H., Barda, N., Mandelboim, M., Lustig, Y., Zuckerman, N. s.
10.64898/2026.01.26.26344903 — Posted: 2026-01-29
A comparison of observation models for statistical inference of emerging disease transmission dynamics: Application to SARS-CoV-2
Domenech de Celles, M., Kramer, S. C.
10.64898/2026.01.27.26344924 — Posted: 2026-01-29
Functional genomic analysis reveals mechanisms of epigenetic interference in SARS-CoV-1 and SARS-CoV-2
Paulson, A. R., Montoya, V., Joy, J. B.
10.64898/2026.01.28.702465 — Posted: 2026-01-29
Balancing data quality and participant burden: A comparative analysis of abbreviated vs extended symptom diaries in the CanTreatCOVID trial
Hosseini, B., Mohammadrezaei, D., Balalaie, P., Sivayoganathan, K., Condon, A., da Costa, B. R., Daley, P., Greiver, M., Jüni, P., Lee, T. C., McBrien, K., McDonald, E. G., Murthy, S. C., Selby, P., Pinto, A. D.
10.64898/2026.01.23.26343617 — Posted: 2026-01-28
Synonymous substitution rate slowdown preceding the emergence of SARS-CoV-2 variants and during persistent infections
Havens, J. L., Gangavarapu, K., Wang, J. C., Taki, F., Luoma, E., Pekar, J. E., Amin, H., Di Lonardo, S., Omoregie, E., Hughes, S., Andersen, K. G., Vasylyeva, T. I., Suchard, M. A., Wertheim, J. O.
10.64898/2026.01.26.26344861 — Posted: 2026-01-28
Diminished EBV-Specific Humoral Immunity is Associated with Neuropsychiatric Long COVID Development up to 12 Months Post-COVID-19 Symptom Onset
Samaan, P., Budylowski, P., Russell, V., Srighanthan, J., M. Cheung, A., Ostrowski, M.
10.64898/2026.01.27.701989 — Posted: 2026-01-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).